HomeADMA • NASDAQ
add
ADMA Biologics Inc
Previous close
$16.08
Day range
$15.48 - $16.52
Year range
$5.02 - $23.63
Market cap
3.79B USD
Avg Volume
2.39M
P/E ratio
58.03
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 119.84M | 78.13% |
Operating expense | 20.02M | 25.38% |
Net income | 35.91M | 1,299.96% |
Net profit margin | 29.96 | 686.35% |
Earnings per share | 0.15 | 1,400.00% |
EBITDA | 41.58M | 285.80% |
Effective tax rate | 2.29% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 86.71M | 16.92% |
Total assets | 390.62M | 11.93% |
Total liabilities | 158.73M | -19.66% |
Total equity | 231.89M | — |
Shares outstanding | 236.39M | — |
Price to book | 16.41 | — |
Return on assets | 25.84% | — |
Return on capital | 29.45% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 35.91M | 1,299.96% |
Cash from operations | 25.03M | 108.83% |
Cash from investing | -1.10M | -45.05% |
Cash from financing | -25.47M | -6,221.88% |
Net change in cash | -1.54M | -113.20% |
Free cash flow | 11.48M | 24.10% |
About
Founded
2004
Headquarters
Website
Employees
624
